Market Cap 52.25B
Revenue (ttm) 6.07B
Net Income (ttm) 1.07B
EPS (ttm) N/A
PE Ratio 32.30
Forward PE 30.26
Profit Margin 17.69%
Debt to Equity Ratio 0.06
Volume 1,844,143
Avg Vol 4,251,834
Day's Range N/A - N/A
Shares Out 575.80M
Stochastic %K 49%
Beta 0.85
Analysts Strong Sell
Price Target $102.03

Company Profile

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provide...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 250 2500
Address:
One Edwards Way, Irvine, United States
11thestate
11thestate Sep. 2 at 1:08 PM
Imagine buying $EW at its peak, only to watch it crash like this and then finding out there’s a way to get some money back. To all $EW investors out there, we’ve got some important news: a $39 million investor settlement is now open for claims from shareholders who purchased shares in 2024. You can check if you’re eligible and claim your share: https://11th.com/cases/edwards-lifesciences-investor-suit
0 · Reply
TalkMarkets
TalkMarkets Aug. 31 at 7:50 PM
Unusual Volume In #EdwardsLifesciences Put Options Shows Investors Bullish On EW Stock $EW https://talkmarkets.com/article/unusual-volume-in-edwards-lifesciences-put-options-shows-investors-bullish-on-ew-stock-1788205833
0 · Reply
heikoscreens
heikoscreens Aug. 27 at 5:52 AM
$EW insider filings just flagged a cluster: 2 different execs, 3 separate sells same day (Aug 26). One sold ~$2.9M (~41% of her position, tied to an option exercise), another sold ~$113K. Thing is, no technical screener is signaling sell on this name - stock's actually up ~6% over the past month. Cluster selling with zero confirming signal underneath it: noise, or worth watching?
1 · Reply
heikoscreens
heikoscreens Aug. 27 at 5:44 AM
$PINS $HSY $EW $SLB $LITE - insider filings through 26 Aug, another all-sell batch, no buys in it. Standout: Pinterest director Silbermann sold again, this time 100% of his remaining stake, zero shares left. He sold ~$1.08M back on 19 Aug too - this one closes it out completely. Rest of the batch: SLB's CEO planned-sold $1.31M, Hershey's trust sold across three separate filings same day (~$1.86M combined, a pattern I've flagged before), two different EW executives sold a combined ~$3M. Doesn't tell me what happens to any of these stocks next, just tracking who's stepping away and how completely. Does a 100%-of-position exit carry more weight for you than a routine partial sell?
1 · Reply
CapitalMonk
CapitalMonk Aug. 22 at 2:10 AM
$EW Price: $89.79 (-0.04%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.36% RSI: 53.8 | Momentum: Moderate Volume: -42.0% vs avg Volatility: 1.44% Support: $81.16 | Resistance: $93.91 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
ZacharyBrooks497
ZacharyBrooks497 Aug. 20 at 7:35 AM
$EW $ADSK $AXON $CTVA $PYPL Edwards Lifesciences benefits from structural-heart procedures, Autodesk benefits from design-software adoption, Axon benefits from public-safety technology spending, Corteva benefits from agricultural demand, and PayPal benefits from digital-payment activity. I'm watching procedure growth, software subscriptions, government contracts, crop conditions, and payment volumes.
0 · Reply
11thestate
11thestate Aug. 18 at 1:09 PM
The Court Finally Approved the $39M Settlement Between Edwards Lifesciences ($EW) and Its Investors over TAVR Growth Claims The case centered on claims that Edwards misled investors about the growth potential of its TAVR business and failed to disclose challenges from newer heart treatments. In 2024, the company lowered its TAVR revenue outlook, and $EW dropped more than 31%. So if you purchased $EW in 2024, you may be eligible to submit your claim: https://11th.com/cases/edwards-lifesciences-investor-suit
0 · Reply
GettnFibbywIT
GettnFibbywIT Aug. 14 at 1:30 PM
$EW $IHI ...EW keeps knocking on that door. This time, is price going to open?
1 · Reply
John_Wick1234
John_Wick1234 Aug. 11 at 12:55 PM
$EW Price Cross Above Supertrend.
0 · Reply
kcphaeton
kcphaeton Aug. 11 at 4:54 AM
$EW liking the steady climb upwards. 
0 · Reply
Latest News on EW
Edwards Lifesciences management to meet with Piper Sandler

2026-08-31T20:35:51.000Z - 3 days ago

Edwards Lifesciences management to meet with Piper Sandler


Edwards Lifesciences upgraded to Buy from Neutral at UBS

2026-07-28T10:41:30.000Z - 5 weeks ago

Edwards Lifesciences upgraded to Buy from Neutral at UBS


Edwards Lifesciences Earnings Call Transcript: Q2 2026

Jul 23, 2026, 5:00 PM EDT - 6 weeks ago

Edwards Lifesciences Earnings Call Transcript: Q2 2026


Edwards Lifesciences Earnings release: Q2 2026

Jul 23, 2026, 5:00 PM EDT - 6 weeks ago

Edwards Lifesciences Earnings release: Q2 2026


Edwards Lifesciences Quarterly report: Q2 2026

Jul 23, 2026, 5:00 PM EDT - 6 weeks ago

Edwards Lifesciences Quarterly report: Q2 2026


Edwards Lifesciences reports Q2 EPS 78c, consensus 74c

2026-07-23T20:22:03.000Z - 6 weeks ago

Edwards Lifesciences reports Q2 EPS 78c, consensus 74c


Edwards Lifesciences sees Q3 EPS 71c-77c, consensus 75c

2026-07-23T20:21:46.000Z - 6 weeks ago

Edwards Lifesciences sees Q3 EPS 71c-77c, consensus 75c


Edwards Lifesciences Reports Second Quarter Results

Jul 23, 2026, 4:15 PM EDT - 6 weeks ago

Edwards Lifesciences Reports Second Quarter Results


East West Announces $858,000 Non-Brokered Private Placement

Jun 12, 2026, 8:00 AM EDT - 2 months ago

East West Announces $858,000 Non-Brokered Private Placement


Edwards Lifesciences Announces Appointment of CFO

May 4, 2026, 4:45 PM EDT - 4 months ago

Edwards Lifesciences Announces Appointment of CFO


Edwards Lifesciences Earnings Call Transcript: Q1 2026

Apr 23, 2026, 5:00 PM EDT - 4 months ago

Edwards Lifesciences Earnings Call Transcript: Q1 2026


Edwards Lifesciences Earnings release: Q1 2026

Apr 23, 2026, 5:00 PM EDT - 4 months ago

Edwards Lifesciences Earnings release: Q1 2026


Edwards Lifesciences Quarterly report: Q1 2026

Apr 23, 2026, 5:00 PM EDT - 4 months ago

Edwards Lifesciences Quarterly report: Q1 2026


Edwards Lifesciences Reports First Quarter Results

Apr 23, 2026, 4:15 PM EDT - 4 months ago

Edwards Lifesciences Reports First Quarter Results


Edwards Lifesciences Proxy statement: Proxy filing

Mar 26, 2026, 8:00 AM EDT - 5 months ago

Edwards Lifesciences Proxy statement: Proxy filing


Edwards Lifesciences Proxy statement: Proxy filing

Mar 26, 2026, 8:00 AM EDT - 5 months ago

Edwards Lifesciences Proxy statement: Proxy filing


Edwards Lifesciences Proxy statement: Proxy filing

Mar 26, 2026, 8:00 AM EDT - 5 months ago

Edwards Lifesciences Proxy statement: Proxy filing


Edwards Lifesciences Earnings Call Transcript: Q4 2025

Feb 10, 2026, 5:00 PM EST - 6 months ago

Edwards Lifesciences Earnings Call Transcript: Q4 2025


Edwards Lifesciences Annual report: Q4 2025

Feb 10, 2026, 5:00 PM EST - 6 months ago

Edwards Lifesciences Annual report: Q4 2025


Edwards Lifesciences Earnings release: Q4 2025

Feb 10, 2026, 5:00 PM EST - 6 months ago

Edwards Lifesciences Earnings release: Q4 2025


Edwards Lifesciences Reports Fourth Quarter Results

Feb 10, 2026, 4:15 PM EST - 6 months ago

Edwards Lifesciences Reports Fourth Quarter Results


Edwards Comments on JenaValve Acquisition

Jan 9, 2026, 6:48 PM EST - 7 months ago

Edwards Comments on JenaValve Acquisition


Edwards Lifesciences Transcript: Investor Day 2025

Dec 4, 2025, 8:30 AM EST - 9 months ago

Edwards Lifesciences Transcript: Investor Day 2025


Edwards Lifesciences Press release: FY 2025

Dec 4, 2025, 8:30 AM EST - 9 months ago

Edwards Lifesciences Press release: FY 2025


Edwards Lifesciences Slides: FY 2025

Dec 4, 2025, 8:30 AM EST - 9 months ago

Edwards Lifesciences Slides: FY 2025


Top small-cap plays for 2026

Nov 25, 2025, 1:24 PM EST - 9 months ago

Top small-cap plays for 2026

A COHR DG TXT VLO


Edwards Lifesciences Earnings Call Transcript: Q3 2025

Oct 30, 2025, 5:00 PM EDT - 10 months ago

Edwards Lifesciences Earnings Call Transcript: Q3 2025


Edwards Lifesciences Quarterly report: Q3 2025

Oct 30, 2025, 5:00 PM EDT - 10 months ago

Edwards Lifesciences Quarterly report: Q3 2025


Edwards Lifesciences Earnings release: Q3 2025

Oct 30, 2025, 5:00 PM EDT - 10 months ago

Edwards Lifesciences Earnings release: Q3 2025


Edwards Lifesciences CFO Scott Ullem to step down by mid-2026

Oct 30, 2025, 4:38 PM EDT - 10 months ago

Edwards Lifesciences CFO Scott Ullem to step down by mid-2026


Edwards Lifesciences Announces CFO Transition Plan

Oct 30, 2025, 4:15 PM EDT - 10 months ago

Edwards Lifesciences Announces CFO Transition Plan


Edwards Lifesciences Reports Third Quarter Results

Oct 30, 2025, 4:13 PM EDT - 10 months ago

Edwards Lifesciences Reports Third Quarter Results


Edwards Lifesciences Transcript: Investor Update

Oct 27, 2025, 9:00 PM EDT - 10 months ago

Edwards Lifesciences Transcript: Investor Update


11thestate
11thestate Sep. 2 at 1:08 PM
Imagine buying $EW at its peak, only to watch it crash like this and then finding out there’s a way to get some money back. To all $EW investors out there, we’ve got some important news: a $39 million investor settlement is now open for claims from shareholders who purchased shares in 2024. You can check if you’re eligible and claim your share: https://11th.com/cases/edwards-lifesciences-investor-suit
0 · Reply
TalkMarkets
TalkMarkets Aug. 31 at 7:50 PM
Unusual Volume In #EdwardsLifesciences Put Options Shows Investors Bullish On EW Stock $EW https://talkmarkets.com/article/unusual-volume-in-edwards-lifesciences-put-options-shows-investors-bullish-on-ew-stock-1788205833
0 · Reply
heikoscreens
heikoscreens Aug. 27 at 5:52 AM
$EW insider filings just flagged a cluster: 2 different execs, 3 separate sells same day (Aug 26). One sold ~$2.9M (~41% of her position, tied to an option exercise), another sold ~$113K. Thing is, no technical screener is signaling sell on this name - stock's actually up ~6% over the past month. Cluster selling with zero confirming signal underneath it: noise, or worth watching?
1 · Reply
heikoscreens
heikoscreens Aug. 27 at 5:44 AM
$PINS $HSY $EW $SLB $LITE - insider filings through 26 Aug, another all-sell batch, no buys in it. Standout: Pinterest director Silbermann sold again, this time 100% of his remaining stake, zero shares left. He sold ~$1.08M back on 19 Aug too - this one closes it out completely. Rest of the batch: SLB's CEO planned-sold $1.31M, Hershey's trust sold across three separate filings same day (~$1.86M combined, a pattern I've flagged before), two different EW executives sold a combined ~$3M. Doesn't tell me what happens to any of these stocks next, just tracking who's stepping away and how completely. Does a 100%-of-position exit carry more weight for you than a routine partial sell?
1 · Reply
CapitalMonk
CapitalMonk Aug. 22 at 2:10 AM
$EW Price: $89.79 (-0.04%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.36% RSI: 53.8 | Momentum: Moderate Volume: -42.0% vs avg Volatility: 1.44% Support: $81.16 | Resistance: $93.91 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
ZacharyBrooks497
ZacharyBrooks497 Aug. 20 at 7:35 AM
$EW $ADSK $AXON $CTVA $PYPL Edwards Lifesciences benefits from structural-heart procedures, Autodesk benefits from design-software adoption, Axon benefits from public-safety technology spending, Corteva benefits from agricultural demand, and PayPal benefits from digital-payment activity. I'm watching procedure growth, software subscriptions, government contracts, crop conditions, and payment volumes.
0 · Reply
11thestate
11thestate Aug. 18 at 1:09 PM
The Court Finally Approved the $39M Settlement Between Edwards Lifesciences ($EW) and Its Investors over TAVR Growth Claims The case centered on claims that Edwards misled investors about the growth potential of its TAVR business and failed to disclose challenges from newer heart treatments. In 2024, the company lowered its TAVR revenue outlook, and $EW dropped more than 31%. So if you purchased $EW in 2024, you may be eligible to submit your claim: https://11th.com/cases/edwards-lifesciences-investor-suit
0 · Reply
GettnFibbywIT
GettnFibbywIT Aug. 14 at 1:30 PM
$EW $IHI ...EW keeps knocking on that door. This time, is price going to open?
1 · Reply
John_Wick1234
John_Wick1234 Aug. 11 at 12:55 PM
$EW Price Cross Above Supertrend.
0 · Reply
kcphaeton
kcphaeton Aug. 11 at 4:54 AM
$EW liking the steady climb upwards. 
0 · Reply
JazzPaw
JazzPaw Aug. 10 at 6:36 PM
$EW Money coming back to this name. The long Covid recession looks over in this business.
0 · Reply
GettnFibbywIT
GettnFibbywIT Aug. 6 at 3:51 PM
$EW $IHI Following a technically significant rejection from the $94 - $96 resistance confluence zone, EW entered a corrective phase characterized by weakening momentum and a loss of support near $87. More recently, price and momentum have begun to stabilize, with weekly RSI recovering above 50 and buyers defending the low-80's price region. While these developments are constructive, the evidence currently supports a trend-repair or stabilization thesis rather than a confirmed bullish continuation thesis. Additional bullish confirmation would likely require sustained price acceptance above $87 and ultimately a successful reclaim/ close again of the $94 - $96 resistance zone, ideally accompanied by improving underlying momentum structure.
0 · Reply
John_Wick1234
John_Wick1234 Aug. 4 at 11:04 AM
$EW Price Cross Above Bollinger Central Line.
0 · Reply
11thestate
11thestate Aug. 3 at 1:18 PM
$EW stock dropped more than 31% after Edwards Lifesciences cut its TAVR revenue outlook, revealing weaker demand than investors had been led to expect leading to a $39 million settlement. If you bought or held $EW in 2024, claims are now open, and you may be eligible to recover part of your losses: https://11th.com/cases/edwards-lifesciences-investor-suit
0 · Reply
FundaTech
FundaTech Jul. 27 at 2:59 PM
$EW Too low
0 · Reply
IN0V8
IN0V8 Jul. 24 at 1:58 PM
$EW Opportunity Deutsche Bank raises target price to $103 from $100 JP Morgan raises target price to $105 from $100 Leerink Partners raises target price to $101 from $87 Leerink Partners ups to outperform from market perform Raymond James raises target price to $103 from $100
0 · Reply
flychicken1991
flychicken1991 Jul. 24 at 1:31 PM
$EW Positive (84%): shares should receive upward price support as the higher 2026 growth outlook raises the prospect of stronger forward revenue and earnings estimates, subject to the size and quality of the revision. Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/2fd5939b5c8bb7b3?utm_source=stocktwits&utm_medium=story_url
0 · Reply
HotDiamondFingers
HotDiamondFingers Jul. 24 at 11:35 AM
edwards is the clean gainer this morning, up ~4.3% premarket. Q2 beat AND they raised full year sales guidance, so the raise is doing the heavy lifting here not just the quarter. gap up on a beat and raise is the setup bulls actually want, real numbers behind the move. now the question is whether $EW holds that gap once the regular session opens.
0 · Reply
DonCorleone77
DonCorleone77 Jul. 24 at 12:25 AM
$THC $EW $INTC $AMAT $KLAC AFTER-HOURS MOVERS: Currently Higher After Earnings: - Tenet Healthcare (THC) up 13.1% - Edwards Lifesciences (EW) up 3.9% - Intel (INTC) up 4.4%; - Semiconductor Equipment companies higher on Intel plans to increase CapEx in FY26 and FY27: Applied Materials (AMAT) up 2.0%, KLA Corp (KLAC) up 1.5%, and LAM Research (LRCX) up 1.7% - Enova International (ENVA) up 6.0% Currently Also Higher: - Safety Insurance Group (SAFT) up 37.9% after announcing acquisition by Mapfre - Amkor Technology (AMKR) up 12.2% after disclosing partnership with Nvidia Currently Lower After Earnings: - MaxLinear (MXL) down 11.6% - JAKKS Pacific (JAKK) down 11.2% - Summit Therapeutics (SMMT) down 5.2% - Robert Half (RHI) down 5.9% - Deckers Outdoor (DECK) down 3.6% - AppFolio (APPF) down 4.2% - Newmont (NEM) down 0.6% - Comfort Systems USA (FIX) down 1.4%
0 · Reply
Estimize
Estimize Jul. 24 at 12:15 AM
$EW reported 0.78 EPS and 1,741 revenue for Q2. http://www.estimize.com/intro/ew?chart=historical&metric_name=eps&utm_content=EW&utm_medium
0 · Reply
EarningsInsider
EarningsInsider Jul. 23 at 10:16 PM
https://www.marketbeat.com/earnings/reports/2026-7-23-edwards-lifesciences-co-stock/ $EW Edwards Lifesciences Earnings Transcript
0 · Reply